ARS Pharmaceuticals (SPRY) Return on Capital Employed [ROCE] (2021 - 2026)
ARS Pharmaceuticals' Return on Capital Employed [ROCE] came in at -104.14% for Q2 2026, down 82.54 percentage points from -21.59% a year earlier and down 25.68 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, ARS Pharmaceuticals' Return on Capital Employed [ROCE] was -59.76%, down 58.62 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a four-year change of -50.92 percentage points (FY2021 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -1.15% in FY2024 (+25.34 pp), -26.49% in FY2023 (-5.09 pp), -21.40% in FY2022 (-12.55 pp) and -8.85% in FY2021.
- The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2021.
- Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of -19.96 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2022 (a gain of 32.52 percentage points), and the weakest in Q2 2026 (a drop of 82.54 percentage points).
- Business Quant data shows SPRY's Return on Capital Employed [ROCE] at -78.46% (Q1 2026), -57.69% (Q4 2025) and -31.06% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | ARS Pharmaceuticals | 404.71 Mn | 260.91 Mn | 20.81 Mn | -104.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -104.14% |
| Mar 31, 2026 | -78.46% |
| Dec 31, 2025 | -57.69% |
| Sep 30, 2025 | -31.06% |
| Jun 30, 2025 | -21.59% |
| Mar 31, 2025 | -8.69% |
| Dec 31, 2024 | -1.18% |
| Sep 30, 2024 | -29.78% |
| Jun 30, 2024 | -26.02% |
| Mar 31, 2024 | -27.35% |
| Dec 31, 2023 | -28.31% |
| Sep 30, 2023 | -30.00% |
| Jun 30, 2023 | -24.08% |
| Mar 31, 2023 | -17.69% |
| Dec 31, 2022 | -13.11% |
| Sep 30, 2022 | 9.53% |
| Jun 30, 2022 | 3.59% |
| Mar 31, 2022 | -4.45% |
| Dec 31, 2021 | -9.78% |
| Sep 30, 2021 | -22.99% |
API Access
ARS Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();